Schmitt Colleen MD Chattanooga, TN - 37404

Schmitt Colleen MD is categorized under Internal Medicine Doctors in Chattanooga, TN and active since 2010.

Schmitt Colleen MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Colleen Schmitt at the company’s single location by writing to 2200 East 3rd St # 200, Chattanooga, Tennessee TN 37404 or by phoning (423) 643-2500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Schmitt Colleen MD
Contact Person: Colleen Schmitt
Address: 2200 East 3rd St # 200, Chattanooga, Tennessee 37404
Phone Number: (423) 643-2500
Website Address: galenmedical.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Schmitt Colleen MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Colleen Schmitt for inquiries that concern Schmitt Colleen MD by calling the company number (423) 643-2500, as your correspondence is most welcome. Additionally, the physical location of the single location of Schmitt Colleen MD can be found at the coordinates 35.03914,-85.26745 as well as the street address 2200 East 3rd St # 200 in Chattanooga, Tennessee 37404.

For its online presence, you may visit Schmitt Colleen MD’s website at galenmedical.com and engage with its social media outlets through on Twitter and on Facebook.